Voxcan

Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcans core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBCs 3R policy and commitment to reduce the number of animals (up to 80%) used in non-clinical studies and to improve animal welfare. In the infectious disease domain, non-clinical studies can be performed at Voxcan up to Biosafety Level 3, meeting the worlds most stringent safety and containment requirements. Voxcan ensures scientific reliability and traceabilit...